Type 1 diabetes genes and pathways shared by humans and NOD mice

LS Wicker, J Clark, HI Fraser, VES Garner… - Journal of …, 2005 - Elsevier
LS Wicker, J Clark, HI Fraser, VES Garner, A Gonzalez-Munoz, B Healy, S Howlett, K Hunter…
Journal of autoimmunity, 2005Elsevier
The identification of causative genes for the autoimmune disease type 1 diabetes (T1D) in
humans and candidate genes in the NOD mouse has made significant progress in recent
years. In addition to sharing structural aspects of the MHC class II molecules that confer
susceptibility or resistance to T1D, genes and pathways contributing to autoimmune
pathogenesis are held in common by the two species. There are data demonstrating a
similar need to establish central tolerance to insulin. Gene variants for the interacting …
The identification of causative genes for the autoimmune disease type 1 diabetes (T1D) in humans and candidate genes in the NOD mouse has made significant progress in recent years. In addition to sharing structural aspects of the MHC class II molecules that confer susceptibility or resistance to T1D, genes and pathways contributing to autoimmune pathogenesis are held in common by the two species. There are data demonstrating a similar need to establish central tolerance to insulin. Gene variants for the interacting molecules IL2 and CD25, members of a pathway that is essential for immune homeostasis, are present in mice and humans, respectively. Variation of two molecules that negatively regulate T cells, CTLA-4 and the tyrosine phosphatase LYP/PEP, are associated with susceptibility to human and NOD T1D. These observations underscore the value of the NOD mouse model for mechanistic studies on human T1D-associated molecular and cellular pathways.
Elsevier